EU Nod Arrives For Viatris’s Ibrance Rival

CHMP Also Issues Positive Opinion For Intas’s Ranibizumab Biosimilar

 
• By Dave Wallace
  
European Medicines Agency Sign Amsterdam
The EMA’s CHMP issued positive opinions for a generic and a biosimilar at its April meeting • Source: Alamy

More from Generics

More from Products